Rein Therapeutics Inc. (RNTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.42M | -3.22M | -3.55M | -6.42M | -6.17M | -4.81M | -3.82M | -8.39M | -5.27M | -10.39M | -1.64M | -3.12M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 44.55% | 33.08% | 7.1% | 23.5% | -17.15% | 53.69% | -132.87% | -169.22% | - | - | - | - |
| Net Income | -5.84M | -31.97M | -5.58M | -6.82M | -5.5M | -40.98M | -5.85M | -8.94M | -7.11M | -7.34M | -1.83M | -1.79M |
| Depreciation & Amortization | 623K | 0 | 0 | 1K | 0 | 0 | 0 | 4K | 59K | 52K | 12K | 12K |
| Stock-Based Compensation | 156K | 257K | 1.45M | 256K | 264K | 133K | 508K | 326K | 150K | 270K | 229K | 300K |
| Deferred Taxes | 0 | -712K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 29.46M | 400K | 0 | 0 | 37M | 0 | 0 | 0 | 178K | -43K | -52K |
| Working Capital Changes | 1.64M | -260K | 186K | 147K | -938K | -964K | 1.52M | 223K | 1.63M | -3.55M | -11K | -1.59M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.29M | -147K | -1.91M | 4.88M | 238K | -168K | 297K | -1.37M | 966K | -3.75M | 348K | -322K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -96K | 542K | 8.5M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -96K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42K | 0 |
| Cash from Financing | 4.65M | 2.4M | 1.9M | 4.71M | 738K | 1K | -446K | 18.26M | 0 | 15.79M | 0 | 0 |
| Debt Issued (Net) | 4.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 354K | 4.3M | 0 | -370K | 737K | 1K | -292K | 10.94M | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -1.9M | 1.9M | 5.08M | 1K | 0 | -154K | 7.33M | 0 | 15.79M | 0 | 0 |
| Net Change in Cash | 1.23M | -833K | -1.67M | -1.71M | -5.44M | -4.81M | -4.26M | 9.88M | -5.27M | 5.24M | -1.1M | 5.38M |
| Free Cash Flow | -3.42M | -3.22M | -3.55M | -6.42M | -6.17M | -4.81M | -3.82M | -8.39M | -5.27M | 0 | -1.64M | -3.12M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 44.55% | 33.08% | 7.1% | 23.5% | -17.15% | - | -132.87% | -169.22% | - | - | - | - |
| FCF per Share | -0.11 | -0.13 | -0.13 | -0.27 | -0.27 | -0.22 | -0.18 | -0.42 | -0.63 | - | -0.36 | -0.69 |
| FCF Conversion (FCF/Net Income) | 0.59x | 0.10x | 0.64x | 0.94x | 1.12x | 0.12x | 0.65x | 938.16x | 741.04x | 1415.86x | 897.65x | 1743.70x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |